Organon & Co.
OGN· NYSE
OGNOrganon & Co.
Filed Feb 27, 2023 · 10-K · 58 days after period end · 0001821825-23-000003
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | $1.49B | $1.60B | $1.61B |
| Net Income | $108.00M | $202.00M | $368.00M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Feb 27, 2023 · 58 d after period end
